Journal article
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Abstract
BACKGROUND: Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited.
METHODS: We conducted a multicenter, randomized, open-label, three-group, controlled trial involving hospitalized patients with suspected or confirmed Covid-19 who were receiving either no supplemental oxygen or a maximum of 4 liters per minute of …
Authors
Cavalcanti AB; Zampieri FG; Rosa RG; Azevedo LCP; Veiga VC; Avezum A; Damiani LP; Marcadenti A; Kawano-Dourado L; Lisboa T
Journal
New England Journal of Medicine, Vol. 383, No. 21, pp. 2041–2052
Publisher
Massachusetts Medical Society
Publication Date
November 19, 2020
DOI
10.1056/nejmoa2019014
ISSN
0028-4793